MedPath

A study of the effectiveness and safety of pars plana vitrecotmy with subretinal oxiglutatione injection for the treatment of refractory macular edema

Not Applicable
Completed
Conditions
macular edema
Registration Number
JPRN-UMIN000015962
Lead Sponsor
Kobe University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) the patients who refused the consent for this study (2) the patient judged to be unsuitable for study participation by doctor in charge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
visual acuity improvement at postoperative 6 months
Secondary Outcome Measures
NameTimeMethod
change of the following parameters at postoperative 6 months from the baseline: (1) macular thickness measured by optical coherence tomography, (2) visual field, (3) electroretinogram
© Copyright 2025. All Rights Reserved by MedPath